Trial Profile
A Four-arm, Single Dose, Two-Period, Pharmacokinetic Study of BiDil SR and IR Capsules and Commercial BiDil Tablets
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Hydralazine/isosorbide dinitrate (Primary)
- Indications Heart failure
- Focus Pharmacokinetics; Registrational
- Sponsors Arbor Pharmaceuticals
- 24 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 May 2012 Status changed from planning to recruiting, according to ClinicalTrials.gov.